#ERPositive
Hold up

we ‘gatekeep’ over things like #ERpositive & #ERnegative #cancers, regular #checkups, #complications, #strokes…

#BirthControl isn’t NOTHING: it is massively impactful

We shouldn’t be using it like #steroids from a #gym #parkinglot
What are the side effects of the birth control pill?
The birth control pill may cause side effects like headaches, nausea, sore breasts, and changes in your period. But they usually go away in a few months.
www.plannedparenthood.org
February 8, 2026 at 5:48 PM
Breakthrough in breast cancer treatment: A randomized phase 2 trial in Nature Medicine shows that combining durvalumab immunotherapy with stereo…

#Breastcancer #Clinicaltrial #Durvalumab #ERpositive #Immunotherapy

#Breastcancer #Clinicaltrial #Durvalumab #ERpositive #Immunotherapy

https://news…
Immunotherapy + radiation benefit hormone-receptor-positive breast cancer
Breakthrough in breast cancer treatment: A randomized phase 2 trial in Nature Medicine shows that combining durvalumab immunotherapy with stereo… #Breastcancer #Clinicaltrial #Durvalumab #ERpositive #Immunotherapy
news.gmj.ge
August 20, 2026 at 3:30 PM
🚀 Zacks Small Cap Research - ATOS: Multiple Catalysts Converge in 2H26
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-atos-multiple-catalysts-converge-in-2h26/
#AtossaTh
e#AtossaTherapeuticsd#ATOSn#Endoxifene#ZEndoxifenn#BreastCancerv#ERpositivet#HER2NegativeN#EVANGELINE
August 15, 2026 at 3:35 AM
The combination of giredestrant + palbociclib produced a numerical PFS improvement in patients with ER-positive/HER2-negative advanced breast cancer. 📊🧬
Read more ➡️ www.onclive.com/view/giredes...
#ASCO26 #BreastCancer #HRPositiveBreastCancer #ERPositive #CDK46 #Oncology #bcsm
Giredestrant Plus Palbociclib Yields Numerical PFS Benefit in ER+, HER2– Advanced Breast Cancer | OncLive
Giredestrant plus palbociclib improved PFS numerically just shy of 5 months in the persevERA trial, but was deemed negative due to lack of statistical significance.
www.onclive.com
June 2, 2026 at 10:17 PM
October 30, 2025 at 1:53 PM